- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01798342
Safety of Gastric Volume Emptying After the Intake of Maltodextrin and Glutamine
Gastric Residual Volume After He Intake Of Maltodextrin And Glutamine. A Randomized Double-Blind, Crossover Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
We included 11 male young volunteers (aged between 21 and 30 years-old) with body mass index (BMI) between 20 and 29 kg/m2 and without either acute or chronic illness in the last 3 months. The criteria for exclusion were non-adherence to any phase of the study protocol, gastroesophageal reflux disease, previous history of intolerance to lactose, gastroparesis or history of poor gastric emptying, diabetes mellitus, and previous abdominal surgery.
Each volunteer was randomized for participation in the study in a blind fashion. All subjects underwent two different protocols before MRI with an interval of seven days between them. Both phases took place after an overnight fast of eight hours. The volunteers ingested 400ml (4 hours before the exam was carried out) at 8:00AM and 200ml (2 hours before the exam was carried out) at 10:00AM of a beverage containing either water plus 12.5% maltodextrin (Phloraceae, Cuiabá, Brazil; CHO group) or the same beverage plus 15g of GLN (Phloraceae, Cuiabá, Brazil; GLN group). The participants were instructed not to ingest alcohol, medication, and caffeine within 24 hours of the study, nor do any vigorous physical activity during that time.
In both phases the individuals were blind to the specific drink and they were told to ingest the beverage in a maximum period of five minutes and T0 was defined as the moment they complete the intake of the solution.The powdered products (maltodextrin alone or maltodextrine plus glutamine) were packed in coded opaque sachets and the content was only known by the pharmacist who manipulated it.
All the participants in the study underwent magnetic resonance of the upper abdomen at 12:00AM and 01:00PM. The GRV observed during the first exam was defined as T120 and the second exam as T180. All exams were performed by the same magnetic resonance equipment (Intera 1.5T ; Philips Healthcare, Eindhoven, Holland).
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Mato Grosso
-
Cuiaba, Mato Grosso, Brazil, 78000-000
- Hospital Santa Rosa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Young male volunteers (aged between 21 and 30 years-old) with body mass index (BMI) between 20 and 29 kg/m2 and without either acute or chronic illness in the last 3 months.
Exclusion Criteria:
- non-adherence to any phase of the study protocol,
- gastroesophageal reflux disease,
- previous history of intolerance to lactose,
- gastroparesis or history of poor gastric emptying,
- diabetes mellitus, and
- previous abdominal surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Maltodextrin
The volunteers ingested 400ml (4 hours before the exam was carried out) at 8:00AM and 200ml (2 hours before the exam was carried out) at 10:00AM of a beverage containing water plus 12.5% maltodextrin
|
The volunteers underwent MRI after the ingestion of the dietary supplement in a crossover fashion aiming at measuring the gastric residual volume
Other Names:
|
|
Experimental: Glutamine
The same volunteers ingested 400ml (4 hours before the exam was carried out) at 8:00AM and 200ml (2 hours before the exam was carried out) at 10:00AM of a beverage containing water plus 12.5% maltodextrin plus 15g of glutamine
|
The volunteers ingested 400ml (4 hours before the exam was carried out) at 8:00AM and 200ml (2 hours before the exam was carried out) at 10:00AM of a beverage containing water plus 12.5% maltodextrin plus 15g of GLN before MRI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastric residual volume (GVR) ("change" is being assessed)
Time Frame: immediately after ingestion (T0), 120 minutes after (T120) and 180 (T180) minutes after ingestion
|
We measured the GRV by MRI immediately after ingestion (T0)and the changes of GVR after 120 (T120)and 180 minutes (T180)- "change" is being assessed
|
immediately after ingestion (T0), 120 minutes after (T120) and 180 (T180) minutes after ingestion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Vomiting
Time Frame: 180 minutes
|
We observed whether the volunteer presented vomiting during the experiment
|
180 minutes
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Respiratory Tract Diseases
- Respiration Disorders
- Gastrointestinal Diseases
- Esophageal Motility Disorders
- Deglutition Disorders
- Esophageal Diseases
- Gastroesophageal Reflux
- Laryngopharyngeal Reflux
- Respiratory Aspiration
- Respiratory Aspiration of Gastric Contents
Other Study ID Numbers
- brianez
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Aspiration of Gastric Contents
-
St Vincent's Hospital MelbourneRecruitingPulmonary Aspiration of Gastric Contents | Residual Gastric ContentsAustralia
-
University Hospital, GenevaCompletedGastric Emptying | Aspiration of Gastric ContentsSwitzerland
-
Uppsala UniversityCompleted
-
KK Women's and Children's HospitalCompletedPulmonary Aspiration of Gastric ContentsSingapore
-
King Saud UniversityCompletedPulmonary Aspiration of Gastric Contents
-
Uppsala University HospitalRecruitingPulmonary Aspiration of Gastric ContentsSweden
-
Johannes Gutenberg University MainzUniversity Medical Center Freiburg; Krankenhaus der Borromaerinnen Trier; Bundeswehrkrankenhaus... and other collaboratorsCompletedPulmonary Aspiration of Gastric ContentsGermany
-
King Edward Medical UniversityCompletedPulmonary Aspiration of Gastric ContentsPakistan
-
Coombe Women and Infants University HospitalCompletedAspiration; Gastric Contents, AnesthesiaIreland
-
Hospices Civils de LyonCompletedPulmonary Aspiration of Gastric ContentsFrance
Clinical Trials on Maltodextrin
-
RDC Clinical Pty LtdCompletedJoint Pain | Muscle Pain | Chronic Inflammation | MobilityAustralia
-
University of ReadingABC Farmaceutici S.p.A.Recruiting
-
Muhammad N Aslam, MDCrohn's and Colitis FoundationNot yet recruitingUlcerative Colitis | Ileal PouchUnited States
-
Chung Shan Medical UniversityCompleted
-
Northwestern UniversityUniversity of Illinois at ChicagoActive, not recruitingParkinson Disease | Dietary Modification | Intestinal Bacteria Flora DisturbanceUnited States
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Central South UniversityHunan Children's HospitalNot yet recruitingObesity | Obese Children and Adolescents | Obese Adolescents | Akkermansia MuciniphilaChina
-
Princess Nourah Bint Abdulrahman UniversityNot yet recruitingInflammation | Obesity | Type 2 Diabetes | Gut Microbiome | Metabolic HealthSaudi Arabia
-
University of ViennaCRI Collagen Research Institute GmbHRecruiting
-
Federal University of Minas GeraisNestle Health ScienceRecruiting